Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Drug-Related Side Effects and Contributing Risk Factors in Children With Congenital Heart Disease: A Cross-Sectional Study Publisher



Toni E1 ; Ayatollahi H2 ; Abbaszadeh R3 ; Siahpirani AF4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Heart Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Institute of Biochemistry and Biophysics (IBB), Department of Bioinformatics, University of Tehran, Tehran, Iran

Source: Health Science Reports Published:2025


Abstract

Background and Aims: Children with congenital heart disease (CHD) often require complex pharmacotherapy for symptom management and complication prevention. However, their unique physiological profiles increase vulnerability to drug-related side effects. This study aimed to identify specialists' perspectives on drug-related side effects and associated risk factors in pediatric CHD patients. Methods: A cross-sectional study was conducted in 2024 involving 20 pediatric cardiologists and pediatric cardiology fellows. Data were collected using two 5-point Likert scale questionnaires assessing commonly prescribed drugs, observed side effects, and associated risk factors in pediatric CHD patients. Data were analyzed using student's t-tests and descriptive statistics. Results: According to the findings, the most frequent side effects linked to common medications were hypokalemia (Furosemide; 4.5 ± 0.69), apnea (Prostaglandin E1; 4.5 ± 0.62), and bradycardia (Sotalol; 4.41 ± 0.51). Dosage and polypharmacy emerged as major risk factors, particularly for drugs like Digoxin and Heparin. Younger age, underlying health conditions, and specific drug combinations also increased the risk of side effects. The t-test revealed significant associations between participants' demographics (sex, age, and work experience) and their perceptions of drug-related side effects and risk factors. Conclusions: The findings emphasize the need for a personalized approach to pharmacotherapy in pediatric CHD patients, requiring careful drug selection, dose optimization, and enhanced monitoring strategies. Drug-related side effects highlight the importance of implementing clinical decision support systems, routine therapeutic drug monitoring, and individualized dosing adjustments to mitigate risks. Future research should prioritize longitudinal studies to establish causality relationships, optimize treatment protocols, and improve medication safety in this vulnerable population. © 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Related Docs
1. Adverse Drug Reactions in Children With Congenital Heart Disease: A Scoping Review, Pediatric Drugs (2024)
2. Assessment of Bendopnea and Its Association With Clinical and Para-Clinical Findings in Systolic Heart Failure: A Cross-Sectional Study, Health Science Reports (2025)
3. Cardiovascular Pharmacology in Pediatric Patients With Congenital Heart Disease, Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management# Second Edition (2023)
4. Endocan As a Biomarker for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis, Health Science Reports (2024)
5. The Relationship of Covid-19 Severity With Laboratory Findings and Neutrophil-To-Lymphocyte Ratio in Patients Admitted to a Large Teaching Hospital in Iran: A Cross-Sectional Study, Health Science Reports (2024)
Experts (# of related papers)
Samira Rajaei (1)
Zahra Khazaeipour (1)